Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06826534 · ClinicalTrials.gov registry record · NA
At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
A NA study of Cardiovascular Complication and Chemotherapeutic Toxicity, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06826534: Recruiting NA study of Cardiovascular Complication and Chemotherapeutic Toxicity, sponsored by Children's Hospital Los Angeles.
NCT06826534 is a NA study of Cardiovascular Complication and Chemotherapeutic Toxicity that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06826534, a NA study of Cardiovascular Complication and Chemotherapeutic Toxicity, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to explore the impact that an at-home cardio-oncology rehabilitation (CORE) may have on short-term cardiovascular fitness and psychosocial wellness in pediatric cancer survivors. The main question it aims to answer are * To evaluate the efficacy of an at-home CORE model on short-term cardiovascular fitness and psychosocial wellbeing in adolescent cancer survivors. * To evaluate the exercise adherence rate among adolescents at risk for heart failure and assess barriers to compliance. * To explore which specific CORE resources are of most value to patients in creating sustainable healthy lifestyle modifications. * Hypothesis: Pediatric cancer survivors who implement exercise and dietary recommendations will demonstrate improvement in cardiovascular fitness and general wellness. A multidisciplinary team approach can facilitate adherence to a moderately rigorous exercise prescription, and thus enhance the health benefits of a CORE program at CHLA. Participants will undergo cardiovascular studies and a quality-of-life survey prior to exercise intervention, and at the end of the 6-month study period.
Primary Outcome
Peak VO2% (exercise capacity) as measured by cardiopulmonary exercise testing.
Conditions Studied
Interventions
- BEHAVIORAL Cardio-oncology rehabilitation
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06826534 shows while recruiting
NCT06826534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cardiovascular Complication appearing as the primary indexed condition, and to 1 intervention - of which Cardio-oncology rehabilitation is the first listed.
NCT06826534 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06826534 about?
NCT06826534 is a clinical study titled "At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure". The goal of this clinical trial is to explore the impact that an at-home cardio-oncology rehabilitation (CORE) may have on short-term cardiovascular fitness and psychosocial wellness in pediatric cancer survivors. The main question it aims to answer are * To evaluate the efficacy of an at-home CORE...
What is the current status of trial NCT06826534?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-10-20. Estimated completion is 2025-12-31.
What conditions does trial NCT06826534 study?
This clinical trial studies the following conditions: Cardiovascular Complication, Chemotherapeutic Toxicity.
What interventions are being tested in trial NCT06826534?
The interventions under investigation include: Cardio-oncology rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06826534?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06826534 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06826534's enrollment target sits among peer trials
20 1769th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI